Reducing the Overall Risk Level in Patients Suffering From Metabolic Syndrome

Clinical trial NCT00821574 · COMPLETED

Trial details

NCT number: NCT00821574
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hypertension, Dyslypidaemia

Start date: 2005-07-01
Primary completion: 2007-03-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.